STOCK TITAN

TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

TransMedics Group (Nasdaq: TMDX), a medical technology company revolutionizing organ transplant therapy, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The event will take place at the InterContinental Boston Hotel on Tuesday, August 13, 2024.

Key details of the presentation:

  • Date: Tuesday, August 13, 2024
  • Time: 9:30 a.m. Eastern Standard Time
  • Location: InterContinental Boston Hotel

Investors and interested parties can access a live and archived webcast of the fireside chat through the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.

TransMedics Group (Nasdaq: TMDX), un'azienda attiva nella tecnologia medica che sta rivoluzionando la terapia per il trapianto di organi, ha annunciato la sua partecipazione alla 44esima Conferenza Annuale sulla Crescita di Canaccord Genuity. L'evento si svolgerà presso l'InterContinental Boston Hotel il martedì 13 agosto 2024.

Dettagli principali della presentazione:

  • Data: Martedì 13 agosto 2024
  • Ora: 9:30 a.m. Eastern Standard Time
  • Posizione: InterContinental Boston Hotel

Investitori e parti interessate possono accedere a una diretta e a una registrazione del webcast della conversazione attraverso la sezione 'Investitori' del sito web di TransMedics all'indirizzo https://investors.transmedics.com/.

TransMedics Group (Nasdaq: TMDX), una empresa de tecnología médica que está revolucionando la terapia de trasplante de órganos, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. El evento se llevará a cabo en el Hotel InterContinental Boston el martes 13 de agosto de 2024.

Detalles clave de la presentación:

  • Fecha: Martes 13 de agosto de 2024
  • Hora: 9:30 a.m. Hora Estándar del Este
  • Ubicación: Hotel InterContinental Boston

Los inversionistas y otras partes interesadas pueden acceder a una transmisión en vivo y archivada de la charla a través de la sección 'Inversores' del sitio web de TransMedics en https://investors.transmedics.com/.

TransMedics Group (Nasdaq: TMDX), 장기 이식 치료를 혁신하는 의료 기술 회사가 Canaccord Genuity 제44회 연례 성장 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2024년 8월 13일 화요일에 인터콘티넨탈 보스턴 호텔에서 개최됩니다.

발표의 주요 세부사항:

  • 날짜: 2024년 8월 13일 화요일
  • 시간: 동부 표준시 9:30 a.m.
  • 위치: 인터콘티넨탈 보스턴 호텔

투자자 및 관심 있는 분들은 TransMedics 웹사이트의 '투자자' 섹션을 통해 화상 대화의 실시간 및 녹화 웹캐스트에 접근할 수 있습니다: https://investors.transmedics.com/.

TransMedics Group (Nasdaq: TMDX), une entreprise de technologie médicale qui révolutionne la thérapie de transplantation d'organes, a annoncé sa participation à la 44ème Conférence Annuelle de Croissance de Canaccord Genuity. L'événement se déroulera au Hôtel InterContinental de Boston le mardi 13 août 2024.

Détails clés de la présentation :

  • Date : Mardi 13 août 2024
  • Heure : 9h30, Heure Normale de l'Est
  • Lieu : Hôtel InterContinental de Boston

Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct et archivé de la discussion via la section 'Investisseurs' du site Web de TransMedics à l'adresse https://investors.transmedics.com/.

TransMedics Group (Nasdaq: TMDX), ein Medizintechnikunternehmen, das die Organtransplantationstherapie revolutioniert, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity angekündigt. Diese Veranstaltung findet am Dienstag, den 13. August 2024, im InterContinental Boston Hotel statt.

Wichtige Details zur Präsentation:

  • Datum: Dienstag, 13. August 2024
  • Uhrzeit: 9:30 Uhr Eastern Standard Time
  • Ort: InterContinental Boston Hotel

Investoren und interessierte Parteien können über den 'Investoren'-Bereich der TransMedics-Website unter https://investors.transmedics.com/ auf ein Live- und Archiv-Webcast des Gesprächs zugreifen.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., July 29, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 44th Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on Tuesday, August 13, 2024, at 9:30 a.m. Eastern Standard Time.

Event: Canaccord Genuity 44th Annual Growth Conference 
Date: Tuesday, August 13, 2024 
Time: 9:30 a.m. ET 

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact: 
Brian Johnston 
631-807-1986 
Investors@transmedics.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-44th-annual-growth-conference-302208688.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the Canaccord Genuity Growth Conference?

TransMedics (TMDX) is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13, 2024, at 9:30 a.m. Eastern Standard Time.

Where can I watch the TransMedics (TMDX) presentation at the Canaccord Genuity conference?

A live and archived webcast of TransMedics' (TMDX) presentation will be available on the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.

What is the focus of TransMedics (TMDX) as a medical technology company?

TransMedics (TMDX) is a medical technology company that focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.

Where is the Canaccord Genuity 44th Annual Growth Conference being held?

The Canaccord Genuity 44th Annual Growth Conference is being held at the InterContinental Boston Hotel.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.84B
33.56M
3.18%
107.49%
19.19%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER